126 related articles for article (PubMed ID: 11392687)
1. VaxGen AIDS vaccine clears phase III safety hurdle again.
AIDS Read; 2001 May; 11(5):246. PubMed ID: 11392687
[No Abstract] [Full Text] [Related]
2. AIDSVAX. VaxGen.
Billich A
Curr Opin Investig Drugs; 2001 Sep; 2(9):1203-8. PubMed ID: 11717805
[TBL] [Abstract][Full Text] [Related]
3. Vaccines.
AIDS Policy Law; 1999 Aug; 14(14):12. PubMed ID: 11367001
[TBL] [Abstract][Full Text] [Related]
4. NIAID collaborates with VaxGen on vaccine studies.
AIDS Patient Care STDS; 1998 Nov; 12(11):874. PubMed ID: 11362049
[No Abstract] [Full Text] [Related]
5. Therapeutic vaccine trails in Thailand.
Churdboonchart V
J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
[TBL] [Abstract][Full Text] [Related]
6. Human trials of experimental HIV vaccines.
Burke DS
AIDS; 1995; 9 Suppl A():S171-80. PubMed ID: 8819583
[No Abstract] [Full Text] [Related]
7. AIDSVAX VaxGen.
Billich A
Curr Opin Investig Drugs; 2004 Feb; 5(2):214-21. PubMed ID: 15043397
[TBL] [Abstract][Full Text] [Related]
8. Social and behavioral issues in phase III HIV preventive vaccine trials.
Grinstead OA
AIDS; 1995; 9 Suppl A():S245-50. PubMed ID: 8819592
[No Abstract] [Full Text] [Related]
9. HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.
Rerks-Ngarm S; Brown AE; Khamboonruang C; Thongcharoen P; Kunasol P
AIDS; 2006 Jul; 20(11):1471-9. PubMed ID: 16847401
[No Abstract] [Full Text] [Related]
10. First large-scale U.S. trial of HIV vaccine begins soon.
AIDS Policy Law; 1998 Jun; 13(12):10. PubMed ID: 11365517
[TBL] [Abstract][Full Text] [Related]
11. Results in for first phase III vaccine trial.
AIDS Patient Care STDS; 2003 Nov; 17(11):607-8. PubMed ID: 14750221
[No Abstract] [Full Text] [Related]
12. Thailand's Prime-Boost HIV Vaccine Phase III.
Trinvuthipong C
Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
[No Abstract] [Full Text] [Related]
13. US and Thai Governments defend HIV/AIDS vaccine trial in Thailand.
Agnew B
Bull World Health Organ; 2004 Mar; 82(3):231. PubMed ID: 15112014
[No Abstract] [Full Text] [Related]
14. Prevention of HIV: vaccine trials show only limited success.
Goldrick BA
Am J Nurs; 2003 May; 103(5):27. PubMed ID: 12762319
[No Abstract] [Full Text] [Related]
15. [Ethical elements in the development of vaccines against HIV/AIDS].
Molina CN
Sidahora; 2001 Oct; ():14-6. PubMed ID: 11776246
[No Abstract] [Full Text] [Related]
16. Lessons from failure--preparing for future HIV-1 vaccine efficacy trials.
Graham BS; Mascola JR
J Infect Dis; 2005 Mar; 191(5):647-9. PubMed ID: 15688276
[No Abstract] [Full Text] [Related]
17. HIV vaccine trial results are an important step forward in developing an effective vaccine, say WHO and UNAIDS.
Rassool GH
J Adv Nurs; 2003 Jul; 43(2):116. PubMed ID: 12886893
[No Abstract] [Full Text] [Related]
18. Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials.
Francis DP; Heyward WL; Popovic V; Orozco-Cronin P; Orelind K; Gee C; Hirsch A; Ippolito T; Luck A; Longhi M; Gulati V; Winslow N; Gurwith M; Sinangil F; Berman PW
AIDS; 2003 Jan; 17(2):147-56. PubMed ID: 12545073
[No Abstract] [Full Text] [Related]
19. First AIDS vaccine tested did not protect, but gives scientific leads.
James JS
AIDS Treat News; 2003 Mar; (389):6. PubMed ID: 12712937
[TBL] [Abstract][Full Text] [Related]
20. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA.
WHO/UNAIDS/IAVI International Expert Group
AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
